A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients
While the most favored nation initiatives have bold aims to lower the cost of drugs, the impact is limited, and in some instances unclear, a case of style over substance.
A physician assistant with no symptoms and a clear colonoscopy was three years from her next screening. A blood test found Stage 3 colon cancer
A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.
Senator Cassidy’s political future may be settled, but his role in confirmation hearings can influence the future of health, scientific integrity and trust in government.
Decision fatigue can quietly affect financial judgment, especially for caregivers and women balancing family, health and career responsibilities.
As international travel surges, infectious diseases present a growing concern, especially given how quickly they can spread through modern air travel. We must prepare.
While PBM reforms that passed earlier this year will spur further changes in the way business is conducted, it’s anti-trust legislation that could have the most impact.
Plastic surgeons used to focus on what the eye sees. They are starting to focus on the biology beneath it
Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product listed doesn’t necessarily mean it’s covered.